197 results on '"Cimmino, Flora"'
Search Results
2. Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial
3. FGFR1 is a potential therapeutic target in neuroblastoma
4. A Comprehensive Review of Sarcoidosis Treatment for Pulmonologists
5. Respiratory Trajectories and Correlation with Serum Biochemical Indices in Spinal and Bulbar Muscular Atrophy.
6. Induction of natural killer antibody-dependent cell cytotoxicity and of clinical activity of cetuximab plus avelumab in non-small cell lung cancer
7. 19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis
8. PBMCs as Tool for Identification of Novel Immunotherapy Biomarkers in Lung Cancer.
9. Computational nucleus specificity for holographic tomography in flow cytometry
10. Data from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy
11. Supplementary Table 1 from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy
12. Supplementary Figure S4 from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy
13. Supplementary Materials and Methods from A High-Content Screening of Anticancer Compounds Suggests the Multiple Tyrosine Kinase Inhibitor Ponatinib for Repurposing in Neuroblastoma Therapy
14. Supplementary Figures from Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma
15. Data from Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma
16. Supplementary Tables from Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma
17. Data from Common Genetic Variants in NEFL Influence Gene Expression and Neuroblastoma Risk
18. Supplementary Tables 1 - 12, Figures 1 - 5 from Common Genetic Variants in NEFL Influence Gene Expression and Neuroblastoma Risk
19. Toward the specificity in QPI 3D tomographic cell flow cytometry holography: recent achievements and perspectives in biomedical sciences
20. HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia
21. The functional variant rs34330 of CDKN1B is associated with risk of neuroblastoma
22. Kinome expression profiling of human neuroblastoma tumors identifies potential drug targets for ultra high-risk patients
23. Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation of OBFC1
24. Additional file 4 of Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial
25. Additional file 1 of Anti-tumor activity of cetuximab plus avelumab in non-small cell lung cancer patients involves innate immunity activation: findings from the CAVE-Lung trial
26. Additional file 1 of FGFR1 is a potential therapeutic target in neuroblastoma
27. FGFR1 is a Potential Therapeutic Target in Neuroblastoma
28. Anti-tumor Activity of Cetuximab Plus Avelumab in Non-Small Cell Lung Cancer Patients Involves Innate Immunity Activation: Findings from the CAVE-Lung Trial
29. Stain-free nucleus identification in holographic learning flow cyto-tomography
30. Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation ofOBFC1
31. Neuroblastoma Cells Classification Through Learning Approaches by Direct Analysis of Digital Holograms
32. Norcantharidin impairs medulloblastoma growth by inhibition of Wnt/β-catenin signaling
33. Label-free microfluidic platform for blood analysis based on phase-contrast imaging
34. Tomographic flow cytometry as the key-enabling technology for label-free liquid biopsy
35. Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation of OBFC1
36. Analysis of DNA from liquid biopsy: new genetic biomarkers for cancer immunotherapy?
37. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility
38. Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2)
39. Raw holograms based machine learning for cancer cells classification in microfluidics
40. A Targeted Gene Panel for Circulating Tumor DNA Sequencing in Neuroblastoma
41. Cover Picture: Perspectives on liquid biopsy for label‐free detection of “circulating tumor cells” through intelligent lab‐on‐chips (View 3/2020)
42. Perspectives on liquid biopsy for label‐free detection of “circulating tumor cells” through intelligent lab‐on‐chips
43. Role of liquid biopsy for thoracic cancers immunotherapy
44. Fine mapping of 2q35 high-risk neuroblastoma locus reveals independent functional risk variants and suggests full-length BARD1 as tumor-suppressor
45. Additional file 1: of HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia
46. Additional file 2: of HIF-1 transcription activity: HIF1A driven response in normoxia and in hypoxia
47. Association ofPARP1polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma
48. Transcription Factors Involved in Tumorigenesis Are Over-Represented in Mutated Active DNA-Binding Sites in Neuroblastoma
49. Functional characterization of full-length BARD1 strengthens its role as a tumor suppressor in neuroblastoma
50. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.